February 27, 2015 7:35 PM ET

Capital Markets

Company Overview of Prism VentureWorks

Executive Profile

Joshua Resnick M.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


Dr. Joshua Resnick, also known as Josh, is a Partner of Prism VentureWorks. Dr. Resnick's investment activity at the firm focuses on medical devices, biopharmaceuticals, and breakthrough diagnostics. Dr. Resnick brings a background in clinical and academic medicine, finance, and entrepreneurship to Prism's life sciences team. His professional experience includes serving as Director of Investments for ASM Resources. At ASM, Dr. Resnick led all investment activities for ...

Corporate Headquarters

75 Second Avenue
Needham, Massachusetts 02494

United States

Phone: 781-302-4000
Fax: --

Board Members Memberships



University of Pennsylvania - The Wharton School
University of Pennsylvania - School of Medicine
Williams College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prism VentureWorks, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.